Cargando…

Diagnostic Value of Fecal Calprotectin (S100 A8/A9) Test in Children with Chronic Abdominal Pain

Objectives. The aim of the study was to establish whether fecal calprotectin concentration (FCC) may be useful in children with chronic abdominal pain to differentiate between inflammatory bowel disease (IBD), other inflammatory gastrointestinal disorders, and functional gastrointestinal disorders....

Descripción completa

Detalles Bibliográficos
Autores principales:	Pieczarkowski, Stanisław, Kowalska-Duplaga, Kinga, Kwinta, Przemko, Tomasik, Przemysław, Wędrychowicz, Andrzej, Fyderek, Krzysztof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126428/ https://www.ncbi.nlm.nih.gov/pubmed/27974886 http://dx.doi.org/10.1155/2016/8089217

Ejemplares similares

Plasma elafin, cathelicidin, and α-defensins are increased in paediatric inflammatory Crohn’s disease and reflect disease location
por: Wędrychowicz, Andrzej, et al.
Publicado: (2021)

Clinical value of serum eosinophilic cationic protein assessment in children with inflammatory bowel disease
por: Wędrychowicz, Andrzej, et al.
Publicado: (2013)

Differences in the intestinal microbiome of healthy children and patients with newly diagnosed Crohn’s disease
por: Kowalska-Duplaga, Kinga, et al.
Publicado: (2019)

Prognostic value of assessment of stool and serum IL-1β, IL-1ra and IL-6 concentrations in children with active and inactive ulcerative colitis
por: Wędrychowicz, Andrzej, et al.
Publicado: (2017)

Effect of Selected Factors on the Serum 25(OH)D Concentration in Women Treated for Breast Cancer
por: Radom, Agnieszka, et al.
Publicado: (2021)

Dependence of Colonization of the Large Intestine by Candida on the Treatment of Crohn’s Disease
por: KOWALSKA-DUPLAGA, KINGA, et al.
Publicado: (2019)

Gastric Lipase Secretion in Children with Gastritis
por: Tomasik, Przemyslaw J., et al.
Publicado: (2013)

Induction of Remission in Pediatric Crohn’s Disease Patients Assessed by the Mucosal Inflammation Noninvasive Index
por: Herman, Roma, et al.
Publicado: (2021)

Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study
por: Manz, Michael, et al.
Publicado: (2012)

Clinical usefulness of the Mucosal Inflammation Noninvasive Index in newly diagnosed paediatric Crohn’s disease patients
por: Herman, Roma B., et al.
Publicado: (2021)

Evaluation of irisin and visfatin levels in very low birth weight preterm newborns compared to full term newborns—A prospective cohort study
por: Mól, Nina, et al.
Publicado: (2018)

Changes in the Intestinal Microbiota Are Seen Following Treatment with Infliximab in Children with Crohn’s Disease
por: Kowalska-Duplaga, Kinga, et al.
Publicado: (2020)

Diagnostic Value of Fecal Calprotectin in Patient with Ulcerative Colitis
por: Zamani, Hamed, et al.
Publicado: (2013)

Infliximab Therapy Could Decrease the Risk of the Development of Thyroid Disorders in Pediatric Patients With Crohn's Disease
por: Furtak, Aleksandra, et al.
Publicado: (2020)

Endogenous Opioids in Crohn’s Disease
por: Martyniak, Adrian, et al.
Publicado: (2023)

Fecal Calprotectin Is Increased in Stroke
por: Park, Shin Young, et al.
Publicado: (2021)

The value of fecal calprotectin in Clostridioides difficile infection: A systematic review
por: Wen, Bao-Jiang, et al.
Publicado: (2022)

Diagnostic Value of Fecal Calprotectin in Children with Gastritis, Duodenitis and Helicobacter Pylori
por: Rafeey, Mandana, et al.
Publicado: (2022)

The prevalence and risk factors of allergic and respiratory symptoms in a regional cohort of extremely low birth weight children (<1000 g)
por: Kwinta, Przemko, et al.
Publicado: (2013)

Elevated fecal calprotectin is linked to psychosocial complexity in pediatric functional abdominal pain disorders
por: Moorman, Erin L., et al.
Publicado: (2021)

The association of conspiracy beliefs and the uptake of COVID-19 vaccination: a cross-sectional study
por: Kowalska-Duplaga, Kinga, et al.
Publicado: (2023)

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

The role of fecal calprotectin in pediatric disease
por: Jeong, Su Jin
Publicado: (2019)

Calprotectin (S100A8/A9) in Familial Mediterranean Fever
por: Pepper, R, et al.
Publicado: (2015)

Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis
por: Urushikubo, Jun, et al.
Publicado: (2018)

Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis
por: Chen, Fang, et al.
Publicado: (2021)

Clinical value of fecal calprotectin for evaluating disease activity in patients with Crohn’s disease
por: Li, Junrong, et al.
Publicado: (2023)

Extraction, isolation, and concentration of calprotectin antigen (S100A8/S100A9) from granulocytes
por: Nilsen, Tom, et al.
Publicado: (2018)

An Inflammation Loop Orchestrated by S100A9 and Calprotectin Is Critical for Development of Arthritis
por: Cesaro, Annabelle, et al.
Publicado: (2012)

Assessment of the function and morphology of the thyroid gland in paediatric patients treated with enzyme replacement therapy due to selected storage diseases – preliminary results of our own research and a review of the literature
por: Furtak, Aleksandra, et al.
Publicado: (2022)

Fecal calprotectin concentration in neonatal necrotizing enterocolitis
por: Yoon, Jung Min, et al.
Publicado: (2014)

Systematic review on fecal calprotectin in cystic fibrosis
por: Lazzarotto, Eduarda Sampaio, et al.
Publicado: (2022)

Fecal Calprotectin Concentrations in Cats with Chronic Enteropathies
por: Riggers, Denise S., et al.
Publicado: (2023)

The Assessment of the Reliability and Validity of the Polish Version of the Adult Vaccine Hesitancy Scale (PL-aVHS) in the Context of Attitudes toward COVID-19 Vaccination
por: Duplaga, Mariusz, et al.
Publicado: (2022)

Optimal cut‐off value of fecal calprotectin for the evaluation of ulcerative colitis: An unsolved issue?
por: Jha, Ashish Kumar, et al.
Publicado: (2018)

Value of Fecal Calprotectin Measurement During the Initial Period of Therapeutic Anti-Tubercular Trial
por: Jo, Hyeong Ho, et al.
Publicado: (2022)

Calprotectin (S100A8/S100A9) and Myeloperoxidase: Co-Regulators of Formation of Reactive Oxygen Species
por: Bøyum, Arne, et al.
Publicado: (2010)

S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis
por: Hansson, Claes, et al.
Publicado: (2014)

From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis
por: Inciarte-Mundo, José, et al.
Publicado: (2022)

Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC
por: Khammanivong, Ali, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0j14fgp26desmojv0q0soqr124